MGC Diagnostics
MGCD
MGCD was delisted on the 28th of December, 2017.
15 hedge funds and large institutions have $7.85M invested in MGC Diagnostics in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
493% more capital inflows, than outflows
Capital inflows: $904K | Capital outflows: $152K
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
7% more funds holding
Funds holding: 14 → 15 (+1)
2.27% more ownership
Funds ownership: 20.54% → 22.81% (+2.3%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$173K |
| 2 |
James Investment Research
Alpha,
Ohio
|
+$8.16K |
| 3 |
Renaissance Technologies
New York
|
+$5.98K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Eagle Global Advisors
Houston,
Texas
|
-$138K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$12K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$2.36K |
| 4 |
Tower Research Capital (TRC)
New York
|
-$90 |
MGCD Hedge Fund Activity: Q4 2016 in Review
15 of the 4,009 institutional investors tracked by Wall St. Rank reported a position in MGC Diagnostics (MGCD) for Q4 2016, worth a combined $7.85M — up 25% from $6.26M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MGCD positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Brandywine Global Investment Management, opening a new position worth an estimated $173K. The largest seller was Eagle Global Advisors, exiting entirely with an estimated $138K sold.
- 15 institutional investors held MGC Diagnostics (MGCD) as of Q4 2016, up from 14 in Q3 2016.
- Funds reported $7.85M of MGC Diagnostics stock for Q4 2016, up 25% quarter-over-quarter.
- 3 funds opened new MGC Diagnostics positions in Q4 2016 and 2 closed out, a net change of +1 holder.
- The largest MGC Diagnostics buyer in Q4 2016 was Brandywine Global Investment Management, an estimated $173K added.
- The largest MGC Diagnostics seller in Q4 2016 was Eagle Global Advisors, an estimated $138K sold.
Based on aggregated 13F filings for Q4 2016.